Pain Medicine News

  • Home
  • Pain Medicine News

Pain Medicine News A publication for the clinician interested in the diagnosis, treatment and management of pain.

Pain Medicine News, the most widely read pain publication in the United States according to Kantar Media, is mailed to 41,828 pain-treating physicians and to 41,152 pain-treating nurse practitioners and physician assistants. It offers extensive coverage of major scientific meetings affecting the specialty, feature articles on topics relevant to practicing provider, in-depth clinical reviews, pract

ice management articles, medical education, as well as a full line of digital media, including the PainMedicineNews.com website, e-Newsletters, and multimedia content.

New real-world outcomes research demonstrated the safety and healthcare resource advantages of Caldolor over ketorolac...
15/11/2024

New real-world outcomes research demonstrated the safety and healthcare resource advantages of Caldolor over ketorolac in both adult and pediatric populations.

https://www.painmedicinenews.com/a/yCYBAA/f

15/11/2024

High-impact chronic pain is more common among people with knee osteoarthritis )when pain is assessed by its effect on physical function rather than pain interference scores.

https://www.painmedicinenews.com/a/ySYBAA/f

The FDA proposed removing the requirement that biosimilar drug manufacturers submit clinical switching studies to demons...
15/11/2024

The FDA proposed removing the requirement that biosimilar drug manufacturers submit clinical switching studies to demonstrate interchangeability between their product and a brand-name reference drug

https://www.painmedicinenews.com/a/xSYBAA/f

The Routine Assessment of Patient Index Data 3 identifies patients in remission. However, RAPID3’s utility is limited be...
13/11/2024

The Routine Assessment of Patient Index Data 3 identifies patients in remission. However, RAPID3’s utility is limited because it cannot confirm that ongoing pain is caused by RA.

https://www.painmedicinenews.com/a/nCYBAA/f

08/11/2024

The FDA will require participating companies to begin providing prepaid drug mail-back envelopes upon request to outpatient pharmacies and other dispensers of opioid analgesics by March 31, 2025.

https://www.painmedicinenews.com/a/cCYBAA/f

When couples in which one of the partners has rheumatoid arthritis cope with the condition together, they experience les...
08/11/2024

When couples in which one of the partners has rheumatoid arthritis cope with the condition together, they experience less psychological distress and have better relationships.

https://www.painmedicinenews.com/a/ayYBAA/f

People with chronic pain are more supportive of expanding access to medical cannabis than physicians; however, a majorit...
31/10/2024

People with chronic pain are more supportive of expanding access to medical cannabis than physicians; however, a majority of both patients and physicians support steps toward increasing access to medical ma*****na.

https://www.painmedicinenews.com/a/KSYBAA/f

30/10/2024

The FDA has approved Roxybond immediate-release Schedule II 10 mg for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

https://www.painmedicinenews.com/a/MCYBAA/f

28/10/2024

The NOPAIN Act is a big legislative win for the pain medicine profession in Washington, but it already requires an amendment to ensure that seniors are covered for nonopioid alternative medicines under Medicare Part D.

https://www.painmedicinenews.com/a/AiYBAA/f

Address


Website

Alerts

Be the first to know and let us send you an email when Pain Medicine News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pain Medicine News:

Videos

Long-term data on buprenorphine’s efficacy for chronic pain is lacking, experts say. https://www.painmedicinenews.com/Multimedia/Article/06-22/Buprenorphine-Chronic-Pain-Long-Term-Data/67172?utm_source=Social&utm_medium=facebook&utm_campaign=0614pren

Although research has shown that buprenorphine is a strong tool in the toolbox for patients with OUD or chronic pain—or sometimes both—far too often, it isn’t available to patients. https://www.painmedicinenews.com/Multimedia/Article/05-22/Buprenorphine-Chronic-Pain-Opioid-Use-Disorder-Access-Poverty-Politics/67039?utm_source=Social&utm_medium=facebook&utm_campaign=0531pren

How does a provider pick which drug will work well for each patient? Carla Marienfeld, MD, explained to us what MOUD criteria she takes into account. https://www.painmedicinenews.com/Multimedia/Article/05-22/Medications-for-Opioid-Use-Disorder-Buprenorphine-Methadone-Naltrexone/66952?utm_source=Social&utm_medium=facebook&utm_campaign=0516moud

Lynn Webster, MD, FACPM, FASAM, thinks many of the regulations, particularly for methadone prescribing, are more political than medically necessarily. “It's been to control people more than it is to help people,” he told us for ON PAIN. https://www.painmedicinenews.com/Multimedia/Article/04-2022/Buprenorphine-Methadone-Opioid-use-Disorder-OUD/66843?utm_source=Social&utm_medium=facebook&utm_campaign=0509rel

Sarah Kawasaki, MD, who works closely with methadone, recounted its history to us in this episode of ON PAIN. https://www.painmedicinenews.com/Multimedia/Article/04-2022/ON-PAIN-Methadones-History-Steeped-in-Stigma-From-Onset-of-Therapy/66782?utm_source=Social&utm_medium=facebook&utm_campaign=0503opmeth

Almost one-third of patients reported muscle pain following COVID-19 infection, and nearly 20% reported joint pain, according to a new study presented at PAINWeek 2021. https://www.painmedicinenews.com/Multimedia/Article/04-2022/COVID-19-Long-Covid-Muscle-Pain-Joint-Pain/66783?utm_source=Social&utm_medium=facebook&utm_campaign=0502lcmj

Whether it is someone advocating for the promotion of opioid-only therapy or those advocating against any opioid use, providers need to realize that “this emperor is wearing no clothes,” Michael Schatman, PhD, CPE, told us at PAINWeek 2021. https://www.painmedicinenews.com/Multimedia/Article/04-22/-This-Emperor-Is-Wearing-No-Clothes-Avoid-One-Therapy-Is-Best-Ideology/66718?utm_source=Social&utm_medium=facebook&utm_campaign=0425emp

Sarah Kawasaki, MD, and Bayla Ostrach, PhD, MA, CIP, spoke with us about their work with patients with opioid use disorder and substance use disorder. https://www.painmedicinenews.com/Multimedia/Article/04-22/ON-PAIN-Medications-for-OUD-Lifesaving-/66756?utm_source=Social&utm_medium=facebook&utm_campaign=0418oplife

We spoke to experts about the current landscape of opioid use disorder care, from providers’ strategies and treatment options to possible policy changes on a regional and national level. https://www.painmedicinenews.com/Multimedia/Article/03-22/ON-PAIN-COVID-19-Mental-Health-and-OUD-Became-a-Perfect-Storm-/66608?utm_source=Social&utm_medium=facebook&utm_campaign=0405opmh

Not only is radiofrequency ablation safe and effective for patients with chronic low back pain, but it also “doesn't burn any bridges to other options,” according to Rene Przkora, MD, PhD. https://www.painmedicinenews.com/Multimedia/Article/03-22/RF-Ablation-Safe-Effective-and-Doesn-t-Burn-Any-Bridges-for-LBP-Patients/66536?utm_source=Social&utm_medium=facebook&utm_campaign=0405rf

You need to have something in your curriculum. We have a problem with opioids in this country, and that stems back to the lack of education.” Amanda Zimmerman, PA-C. https://www.painmedicinenews.com/Multimedia/Article/03-22/Pain-Education-Lacking-for-NP-PAs-Even-for-New-Graduates/66428?utm_source=Social&utm_medium=facebook&utm_campaign=0321np

Michael Schatman, PhD, CPE, explained how far-reaching the effects of inadequate care can be for pain patients. https://www.painmedicinenews.com/Multimedia/Article/03-22/Decrease-in-Interdisciplinary-Care-Negatively-Affects-Pain-Patients/66397?utm_source=Social&utm_medium=facebook&utm_campaign=0314nega

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Videos
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share